• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯化托品在神经源性逼尿肌过度活动患者中的应用经验

[Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].

作者信息

Shvarts P G, Kadykov A S, Shvedkov V V, Timerbaeva S L, Polevaia E V, Mulach A N

出版信息

Urologiia. 2009 Sep-Oct(5):24-9.

PMID:20213911
Abstract

Overactive bladder (OAB) is observed in such brain diseases as stroke, hypoxic ischemic encephalopathy, Parkinson's disease (PD), multiple sclerosis (MS). Trospium chloride (spasmex) was used in OAB patients with MS (n = 87), stroke (n = 83), encephalopathy (n = 47) and PD (n = 36) in doses from 15 to 45 mg/day in 2 to 36 month courses. The response with minimal side effects was achieved in 94% patients. In addition to basic effects, trospium chloride relieved spastic constipation in patients with stroke, hypersalivation in PD and anal incontinence in MS.

摘要

膀胱过度活动症(OAB)见于多种脑部疾病,如中风、缺氧缺血性脑病、帕金森病(PD)、多发性硬化症(MS)。氯化托烷司琼(斯帕沙星)用于患有MS(n = 87)、中风(n = 83)、脑病(n = 47)和PD(n = 36)的OAB患者,剂量为15至45毫克/天,疗程为2至36个月。94%的患者取得了副作用最小的疗效。除了基本疗效外,氯化托烷司琼还缓解了中风患者的痉挛性便秘、PD患者的唾液分泌过多以及MS患者的肛门失禁。

相似文献

1
[Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].氯化托品在神经源性逼尿肌过度活动患者中的应用经验
Urologiia. 2009 Sep-Oct(5):24-9.
2
[Trospium chloride in the treatment of idiopathic and neurogenic detrusor overactivity].氯化托品在特发性和神经源性逼尿肌过度活动治疗中的应用
Urologiia. 2005 Jul-Aug(4):56-9.
3
[High-dose trospium chloride in therapy of detrusor hyperreflexia].[高剂量氯化托烷司琼治疗逼尿肌反射亢进]
Urologe A. 1991 Jul;30(4):260-3.
4
Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.每日一次服用曲司氯铵治疗膀胱过度活动症有效且耐受性良好:一项多中心III期试验的结果
J Urol. 2007 Sep;178(3 Pt 1):978-83; discussion 983-4. doi: 10.1016/j.juro.2007.05.058. Epub 2007 Jul 16.
5
Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder.托特罗定缓释片每日一次治疗男性膀胱过度活动症的安全性和疗效。
Urology. 2011 Jan;77(1):24-9. doi: 10.1016/j.urology.2010.07.469. Epub 2010 Oct 23.
6
[Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions].[曲司氯铵(斯帕美克斯)治疗脊椎源性病变所致神经源性膀胱过度活动症患者下尿路症状]
Urologiia. 2007 May-Jun(3):15-9.
7
Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.基线尿失禁严重程度可预测每日一次接受托特罗定延长释放治疗后达到无尿失禁的患者比例。
Int J Clin Pract. 2009 Jun;63(6):973-6. doi: 10.1111/j.1742-1241.2009.02065.x. Epub 2009 May 4.
8
Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage.通过将推荐的抗毒蕈碱剂量加倍来治疗神经源性膀胱。
Neurourol Urodyn. 2006;25(5):441-5. doi: 10.1002/nau.20289.
9
Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily.氯化托品在逼尿肌过度活动患者中的应用:每日两次服用20mg氯化托品疗效和安全性的安慰剂对照、随机、双盲、多中心临床试验的荟萃分析
Int J Clin Pharmacol Ther. 2002 Jul;40(7):295-303.
10
[Trospium chloride in combined treatment of females with genital prolapse and overactive urinary bladder].氯化曲司氯铵联合治疗女性生殖器脱垂和膀胱过度活动症
Urologiia. 2008 Sep-Oct(5):16-9.

引用本文的文献

1
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.多发性硬化症的对症治疗:一种临床实践中多模式方法的综述。
Ther Adv Neurol Disord. 2011 May;4(3):139-68. doi: 10.1177/1756285611403646.